Lehrstuhl für Physiologie

Tebentafusp als neuartige Immuntherapie zeigt einen Überlebensvorteil beim metastasierten Uveamelanom und wird bereits in Deutschland eingesetzt. (2022) Hassel JC, Berking C Journal article A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) Koch E, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, Dörrie J, Schuler-Thurner B Journal article Soluble CD83 promotes cutaneous wound healing in an IDO-and beta-catenindependent manner (2022) Royzman D, Peckert-Maier K, Stich L, Wild A, Ostalecki C, Kiesewetter F, Seyferth S, et al. Conference contribution Nectin-1 determines the susceptibility of malignant melanoma to oncolytic herpes simplex virus in vitro and in vivo (2022) Schwertner B, Lindner G, Stauner CT, Klapproth E, Magnus C, Rohrhofer A, Gross S, et al. Conference contribution Dissecting the IFN gamma-mediated transcriptomic alterations in Merkel cell carcinoma cell lines using Nanopore sequencing (2022) Sauerer T, Lischer C, Berking C, Vera González J, Dörrie J Conference contribution Reporting Quality of Studies Developing and Validating Melanoma Prediction Models: An Assessment Based on the TRIPOD Statement (2022) Kaiser I, Diehl K, Heppt M, Mathes S, Pfahlberg AB, Steeb T, Uter W, Gefeller O Journal article Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity (2022) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Malignome als Ursache von chronischen Wunden (2022) Siegling M, Erfurt-Berge C Journal article Evaluation of Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) (2022) Kaiser I, Mathes S, Pfahlberg A, Uter W, Heppt M, Steeb T, Diehl K, Gefeller O Conference contribution Onkologische Systemtherapie bis zum bitteren Ende? (2022) Berking C Journal article